Table 1. Characteristics of patients.
ACEI/ARB: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers; CCB: calcium channel blocker; BB: beta blocker; ICU: intensive care unit; HT: hypertension.
| Sex | ||
| Male (n %) | 42 | 54.5 |
| Female (n %) | 35 | 45.5 |
| Age (mean/SD) | 58.26 | 12.59 |
| Comorbidity | ||
| Geriatric (age>60 years old) (n %) | 31 | 40.26 |
| DM (n %) | 38 | 49.35 |
| HT (n %) | 39 | 50.65 |
| Heart Disease (n %) | 8 | 10.39 |
| Chronic Kidney Disease (n %) | 6 | 7.79 |
| Obesity (n %) | 2 | 2.60 |
| Anti-Hypertensive Drugs | ||
| Single | ||
| ACEI/ARB (n %) | 14 | 18.18 |
| CCB (n %) | 22 | 28.57 |
| BB (n %) | 11 | 14.29 |
| Double | ||
| ACEI/ARB+CCB (n %) | 13 | 16.88 |
| ACEI/ARB+BB (n %) | 7 | 9.09 |
| CCB+BB (n %) | 4 | 5.19 |
| Triple | ||
| ACEI/ARB+CCB+BB (n %) | 6 | 7.79 |
| Severity of COVID-19 | ||
| Moderate (n %) | 43 | 55.84 |
| Severe (n %) | 9 | 11.69 |
| Critically Ill (n %) | 25 | 32.47 |
| Severity of chest x-ray | ||
| Normal (n %) | 12 | 15.58 |
| Mild (n %) | 14 | 18.18 |
| Moderate (n %) | 14 | 18.18 |
| Severe and Critcally ill (n %) | 36 | 46.75 |
| Symptom and duration | ||
| Dyspnea (% days) | 42.9 | 3.1 |
| Fever (% days) | 49.4 | 2.79 |
| Cough (% days) | 59.7 | 5.79 |
| Nausea and vomiting (% days) | 14.3 | 4.1 |
| Diarrhea (% days) | 11.7 | 3.57 |
| Malaise(% days) | 18.2 | 3.64 |
| Flu (%. days) | 7.8 | 4.16 |
| Headache (% days) | 3.9 | 4 |
| Vital signs | ||
| Systolic pressure (mean SD) | 140.78 | 26.78 |
| Diastolic pressure (mean SD) | 82.9 | 13.61 |
| Pulse (mean SD) | 101.88 | 15.46 |
| Respiration rate (mean SD) | 25.51 | 5.67 |
| Temperature (mean SD) | 36.96 | 0.92 |
| Oxygen saturation (mean SD) | 92.42 | 5.79 |
| Laboratory | ||
| Leucocyte (10 3/uL; mean SD) | 10.36 | 6.16 |
| Lymphocyte absolute (10 3/uL mean SD) | 1.38 | 1.01 |
| Neutrophil-lymphocyte ratio (NLR) (mean SD) | 7.05 | 4.63 |
| Thrombocyte (10 3/uL; mean SD) | 275.17 | 105.6 |
| C-Reactive protein (mg/L; mean SD) | 72.5 | 53.44 |
| Procalcitonin (ng/ml; mean. SD) | 4.48 | 10.8 |
| Basal urea nitrogen (mg/dl; mean SD) | 24.5 | 29.92 |
| Creatinine (mg/dl; mean SD) | 1.97 | 3.06 |
| Aspartate aminotransferase (u/L; mean SD) | 128.36 | 411.75 |
| Alanine aminotransferase (u/L; mean SD) | 78.1 | 147.35 |
| D-Dimer (mcg/ml; mean. SD) | 2.13 | 4.57 |
| Glucose (mg/dl; mean SD) | 198.38 | 130.72 |
| PaO2:FiO2 ratio (mean SD) | 209.16 | 177.83 |
| Length of Stay (mean SD) | 13.73 | 6.69 |
| ICU admission (n %) | 18 | 23.4 |
| ARDS (n %) | 15 | 19.5 |
| Ventilator (n %) | 12 | 15.6 |
| Outcome | ||
| Discharge (n %) | 58 | 75.3 |
| Death (n %) | 12 | 15.6 |
DM, diabetes mellitus; HT, hypertension; ACE, angiotensin-converting enzyme inhibitors; ARB, angiotensin receptor blockers; BB, beta blocker; CCB, calcium channel blocker; ICU, intensive Care Unit; SD, standard deviation.